CNT2 inhibitor-1 is primarily used in research and therapeutic applications targeting the concentrative nucleoside transporter 2 (CNT2). Its main application lies in studying nucleoside transport mechanisms, which are crucial for understanding cellular uptake of nucleosides and nucleoside-derived drugs. By inhibiting CNT2, it helps researchers explore its role in conditions like cancer, viral infections, and inflammatory diseases, where nucleoside transport is often dysregulated. Additionally, it is investigated for its potential to enhance the efficacy of nucleoside-based therapies by modulating drug uptake in specific tissues or cells. This compound is particularly valuable in preclinical studies aimed at developing targeted treatments for diseases influenced by nucleoside metabolism.